UPDATE 1-Ebola vaccine doses to be stockpiled for emergency outbreak use
The global vaccine alliance GAVI said on Thursday it had agreed to fund and create a $178 million stockpile of Ebola vaccines for emergency use in outbreaks.
The aim is for a global stock of 500,000 doses of vaccine against the deadly haemorrhagic fever, GAVI said in a statement. The stockpiling will start with Merck's newly developed Ervebo vaccine, which won regulatory approval last month. The plan is for poor and middle-income countries to be able to access the stockpile free of charge, GAVI said, while other countries will need to refund the cost of any vaccines used.
GAVI is a public-private partnership backed by the Bill & Melinda Gates Foundation, the World Health Organization, the World Bank, UNICEF and others, which arranges bulk buys to reduce vaccine costs for poor countries.
ALSO READ
-
Tanzania’s Economy Gains Momentum, but Better Jobs Hold the Key to Broader National Prosperity
-
Tanzania’s Growing Economy Puts Better Jobs at the Heart of Its Next Growth Chapter
-
From Debt Pressure to AfCFTA: Africa Searches for a New Formula to Finance Growth and Jobs
-
World Bank Backs Tonga’s Push for Better Jobs and Business Growth With $15M Grant
-
Clean Energy’s $2 Trillion Funding Challenge Puts People and Nature in the Spotlight
Google News